Intratumor genetic heterogeneity of breast carcinomas as determined by fine needle aspiration and TaqMan low density array

Cellular Oncology

Volumn 29, Issue 5, 2007, Pages 361-372

  Lyng, Maria B ^a,b,c   Lænkholm, Anne Vibeke ^a   Pallisgaard, Niels ^a   Vach, Werner ^b   Knoop, Ann ^a   Bak, Martin ^a   Ditzel, Henrik J ^a,b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Medical Biotechnology Center   (Denmark)

Author keywords

Breast cancer; Fine needle aspiration; Gene expression; Genetic heterogeneity; Quantitative real time PCR

Indexed keywords

ESTROGEN RECEPTOR; RNA;

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CANCER PATIENT; CANCER SURGERY; CLUSTER ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE EXPRESSION; GENE TARGETING; GENETIC HETEROGENEITY; HUMAN; HUMAN TISSUE; MEDICAL DECISION MAKING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TUMOR BIOPSY; UNINDEXED SEQUENCE;

BIOPSY, FINE-NEEDLE; BREAST; BREAST NEOPLASMS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; GENETIC HETEROGENEITY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; STATISTICS, NONPARAMETRIC;

EID: 34547909628     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Early Breast Cancer Trialists' Collaborative Group, Tamoxifen for early breast cancer: an overview of the randomised trials, Lancet 351 (1998), 1451-1467.
2. L.V. Abruzzo, K.Y. Lee, A. Fuller, A. Silverman, M.J. Keating, L.J. Medeiros and K.R. Coombes, Validation of oligonucleotide microarray data using microfluidic low-density arrays: a new statistical method to normalize real-time RT-PCR data, Biotechniques 38 (2005), 785-792.
3. L. Assersohn, L. Gangi, Y. Zhao, M. Dowsett, R. Simon, T.J. Powles and E.T. Liu, The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses, Clin. Cancer Res. 8 (2002), 794-801.
4. P. Boyle, Breast cancer control: signs of progress, but more work required, Breast 14 (2005), 429-438.
5. P. de Cremoux, I. Bieche, C. Tran-Perennou, S. Vignaud, E. Boudou, B. Asselain, R. Lidereau, H. Magdelenat, V. Becette, B. Sigal-Zafrani and F. Spyratos, Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reaction, Endocr. Relat. Cancer 11 (2004), 489-495.
6. L.K. Diaz and N. Sneige, Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy, Adv. Anat. Pathol. 12 (2005), 10-19.
7. S.M. Domchek and B.L.Weber, Recent advances in breast cancer biology, Curr. Opin. Oncol. 14 (2002), 589-593.
8. S. Friberg and S. Mattson, On the growth rates of human malignant tumors: implications for medical decision making, J. Surg. Oncol. 65 (1997), 284-297.
9. A.B. Goulter, D.W. Harmer and K.L. Clark, Evaluation of low density array technology for quantitative parallel measurement of multiple genes in human tissue, BMC Genomics 7 (2006), 34.
10. R.S. Herbst, D.F. Bajorin, H. Bleiberg, D. Blum, D. Hao, B.E. Johnson, R.F. Ozols, G.D. Demetri, P.A. Ganz, M.G. Kris, B. Levin, M. Markman, D. Raghavan, G.H. Reaman, R. Sawaya, L.M. Schuchter, J.W. Sweetenham, L.T. Vahdat, E.E. Vokes, R.J. Winn and R.J. Mayer, Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening - a report from the American Society of Clinical Oncology, J. Clin. Oncol. 24 (2006), 190-205.
11. M. Labuhn, V. Vuaroqueaux, F. Fina, A. Schaller, I. Nanni-Metellus, W. Kung, S. Eppenberger-Castori, P.M. Martin and U. Eppenberger, Simultaneous quantitative detection of relevant biomarkers in breast cancer by quantitative real-time PCR, Int. J. Biol. Markers 21 (2006), 30-39.
12. E.H. Lim, A. Aggarwal, T. Agasthian, P.S. Wong, C. Tan, E. Sim, L. Tan, P.S. Goh, S.C. Wang, K.L. Khoo, A. Mukherjee, S.M. Khoo, G. Chua, B. Nilsson, K.H. Lee and P. Tan, Feasibility of using low-volume tissue samples for gene expression profiling of advanced non-small cell lung cancers, Clin. Cancer Res. 9 (2003), 5980-5987.
13. K.J. Livak and T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods 25 (2001), 402-408.
14. L.A. Newman, Management of patients with locally advanced breast cancer, Curr. Oncol. Rep. 6 (2004), 53-61.
15. L. Ozzello, C. DeRosa, D.V. Habif and G.L. Greene, An immunohistochemical evaluation of progesterone receptor in frozen sections, paraffin sections, and cytologic imprints of breast carcinomas, Cancer 67 (1991), 455-462.
16. J.S. Reis-Filho, C.Westbury and J.Y. Pierga, The impact of expression profiling on prognostic and predictive testing in breast cancer, J. Clin. Pathol. 59 (2006), 225-231.
17. I. Smith and S. Chua, Medical treatment of early breast cancer. IV: Neoadjuvant treatment, BMJ 332 (2006), 223-224.
18. W.F. Symmans, M. Ayers, E.A. Clark, J. Stec, K.R. Hess, N. Sneige, T.A. Buchholz, S. Krishnamurthy, N.K. Ibrahim, A.U. Buzdar, R.L. Theriault, M.F. Rosales, E.S. Thomas, K.M. Gwyn, M.C. Green, A.R. Syed, G.N. Hortobagyi and L. Pusztai, Total RNA yield and microarray gene expression pro-files from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma, Cancer 97 (2003), 2960-2971.
19. J.P. van Netten, I.G. Thornton, S.J. Carlyle, M.L. Brigden, P. Coy, N.L. Goodchild, S. Gallagher and E.J. George, Multiple microsample analysis of intratumor estrogen receptor distribution in breast cancers by a combined biochemical/immunohistochemical method, Eur. J. Cancer Clin. Oncol. 23 (1987), 1337-1342.
20. E. Wang, L.D. Miller, G.A. Ohnmacht, S. Mocellin, A. Perez-Diez, D. Petersen, Y. Zhao, R. Simon, J.I. Powell, E. Asaki, H.R. Alexander, P.H. Duray, M. Herlyn, N.P. Restifo, E.T. Liu, S.A. Rosenberg and F.M. Marincola, Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness, Cancer Res. 62 (2002), 3581-3586.
21. T.J. Yeatman, The future of cancer management: translating the genome, transcriptome, and proteome, Ann. Surg. Oncol. 10 (2003), 7-14.